CLASS I ONGOING Device recall · Reported 2 Jul 2025 · FDA Enforcement Report

Extended Tip Applicator, Box recalled by Integra LifeSciences Corp.

Integra LifeSciences Corp. (NeuroSciences) is recalling Extended Tip Applicator, Box of 5, distributed nationwide in the US. The recall was initiated on 22 May 2025 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesModel/Catalog Number: 205115; UDI: 10381780000150; All Lots.
Quantity recalled2,524 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1959-2025
FDA event ID
96934
Recalling firm
Integra LifeSciences Corp. (NeuroSciences), Princeton, NJ
Classification
Class I
Status
Ongoing
Recall initiated
22 May 2025
FDA classified
20 Jun 2025
Reported
2 Jul 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

22 May 2025Recall initiated by company
20 Jun 2025Classified by FDA+29 days
2 Jul 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Devices contain potentially out-of-specification levels of endotoxins and lack of sterility assurance.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Extended Tip Applicator, 15 CM, Box of 5.

Where it was distributed

Domestic: Nationwide Distribution; Foreign: Canada, Japan, Australia, New Zealand, Taiwan (Province of China), Mexico, Colombia, Dominican Republic (the), Singapore, Mongolia, Hong Kong, Chile, Argentina, Puerto Rico, El Salvador, Guatemala, Korea (the Republic of), Peru, Costa Rica, Panama, From Belgium, distributed to: Austria, Belgium, Cyprus, Czechia, France, Georgia, Germany, Greece, Hungary, Iran (Islamic Republic of), Ireland, Italy, Jordan, Malta, Netherlands (the), Nigeria, Palestine, State of, Portugal, Romania, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey.

Nationwide GeorgiaPuerto Rico

Questions about this recall

Why was it recalled?

Devices contain potentially out-of-specification levels of endotoxins and lack of sterility assurance.

Which lots are affected?

Model/Catalog Number: 205115; UDI: 10381780000150; All Lots.

Where was it sold?

Domestic: Nationwide Distribution; Foreign: Canada, Japan, Australia, New Zealand, Taiwan (Province of China), Mexico, Colombia, Dominican Republic (the), Singapore, Mongolia, Hong Kong, Chile, Argentina, Puerto Rico, El Salvador, Guatemala, Korea (the Republic of), Peru, Costa Rica, Panama, From Belgium, distributed to: Austria, Belgium, Cyprus, Czechia, France, Georgia, Germany, Greece, Hungary, Iran (Islamic Republic of), Ireland, Italy, Jordan, Malta, Netherlands (the), Nigeria, Palestine, State of, Portugal, Romania, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 96934

More recalls from Integra LifeSciences Corp. (NeuroSciences)

All 31

Other Other Medical Devices recalls

All 13,778